Intramyocardial Hemorrhage Leads to Higher MACE Rate by Increasing Myocardial Infarction Volume in Patients with STEMI
Zhijian Wu,Xiaotian Jin,Ilyas Tudahun,Shangjie Wu,Mingxian Chen,Jianjun Tang
DOI: https://doi.org/10.2147/ijgm.s444360
IF: 2.145
2024-01-25
International Journal of General Medicine
Abstract:Zhijian Wu, 1– 3 Xiaotian Jin, 1 Ilyas Tudahun, 1 Shangjie Wu, 2, 3 Mingxian Chen, 1 Jianjun Tang 1 1 Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, 410011, People's Republic of China; 2 Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People's Republic of China; 3 Hunan Centre for Evidence-Based Medicine, Changsha, 410011, People's Republic of China Correspondence: Jianjun Tang; Mingxian Chen, Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, No. 139 Middle Renmin Road, Furong District, Changsha, Hunan, 410011, People's Republic of China, Fax + 86 731 85533525, Email ; Background and Aims: Whether IMH can directly cause persistent myocardial necrosis after reperfusion therapy in STEMI patients is still unclear. We conducted a prospective study to compare the cardiovascular parameters in patients with STEMI with and without IMH to explore the potential correlations between IMH and poor outcomes. Methods and Results: We prospectively enrolled 65 consecutive patients with newly diagnosed STEMI admitted to the CCU of the Second Xiangya Hospital of Central South University between April 2019 and November 2021, all of whom underwent primary PCI. Of these, 38 (58.5%) and 27 (41.5%) patients were in the IMH-absent and IMH-present groups, respectively. At a mean time of 5– 7 days after reperfusion therapy, the volume of MI measured using LGE sequence was larger in STEMI patients with IMH than in patients without IMH (34.2 ± 12.7 cm 3 vs 21.1 ± 13.1 cm 3 , P < 0.001). HsTNT levels were significantly higher in the IMH-present group than in the IMH-absent [2500.0 (1681.5– 4307.0) pg/mL vs 1710.0 (203.0– 3363.5) pg/mL, P =0.021] group during hospitalization. The LVEF measured using CMR in the IMH-present group was lower than that in the IMH-absent group (30.7 ± 9.8% vs 42.3 ± 11.0%, P < 0.001). The rate of MACE at 12 months in IMH-present group was significantly higher than in the IMH-absent group (9/27 VS 2/38, P = 0.012). Conclusion: IMH can lead to further expansion of MI volumes in patients with STEMI, resulting in lower LVEF and higher MACE rate in the post-discharge follow-up. Keywords: myocardial infarction, cardiac magnetic resonance, intramyocardial hemorrhage, infarction volume, outcome Acute ST-segment elevation myocardial infarction (STEMI) is an emergency, severe cardiovascular disease. After the 1970s and the 1980s, with the introduction of reperfusion therapies such as thrombolysis, percutaneous coronary intervention (PCI), and coronary artery bypass graft surgery (CABG) in the treatment of acute myocardial infarction (AMI), the survival rate of patients with STEMI has greatly improved. 1,2 However, cardiac function does not fully recover in 30–50% of patients, even with vascularization therapy, owing to irreversible myocardial necrosis, ischemia-reperfusion injury (IRI), and other factors. 3,4 IRI often results in coronary microvascular injury, which includes two manifestations: intramyocardial hemorrhage (IMH) and microvascular obstruction (MVO), which can be visualized by cardiac magnetic resonance (CMR). 5,6 Although epicardial vascular patency recovered because of microvascular injury, the vascular endothelial gap and erythrocyte exosmosis increased IMH. 7 Previous studies 8–10 have shown that patients with IMH have a worse prognosis. Some cardiologists have proposed that IMH can cause adverse left ventricular remodeling, and myocardial injury is further aggravated due to blood cell extravasation, iron deposition, and local inflammatory reaction. 11 Despite various speculations, the specific mechanism by which IMH contributes to an adverse prognosis remains unclear. Additionally, clinical questions have plagued us. STEMI patients with IMH usually present with more severe conditions and higher laboratory test results such as troponin and NT-ProBNP levels. These conditions indicate that patients with STEMI and IMH are likely to have worse clinical outcomes. This may be related to infarct volume or infarct area. Whether IMH is a concomitant phenomenon of severe MI or might IMH be involved in the worsening progression of MI remains unclear. Therefore, we conducted a prospective study to compare the cardiovascular parameters in patients with STEMI with and without IMH to explore the potential pathophysiological correlations between IMH and poor cardiovascular outcomes. We prospectively enrolled consecutive patients with newly diagnosed STE -Abstract Truncated-
medicine, general & internal